Bulletin
Investor Alert

New York Markets After Hours

Market Pulse Archives

July 10, 2020, 8:10 a.m. EDT

Biotech Nkarta prices IPO at $18 a share, above its price range

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Nkarta Inc. (NKTX)
  • X
    Renaissance IPO ETF (IPO)
  • X
    iShares Nasdaq Biotechnology ETF (IBB)

or Cancel Already have a watchlist? Log In

By Ciara Linnane

Nkarta Inc. /zigman2/quotes/219228443/composite NKTX +0.45% priced its initial public offering Friday at $18 a share, above its price range of $16 to $17, selling 14 million shares to raise about $252 million. The company upsized the deal on Thursday and raised the price range from a prior plan to offer 10 million shares priced at $14 to $16 a share. Cowen, Evercore ISI, Stifel and Mizuho Securities are the joint bookrunning managers of the IPO. The stock is expected to start trading on Nasdaq later Friday under the ticker symbol "NKTX." Nkarta is looking to go public at a time that the Renaissance IPO ETF /zigman2/quotes/207665280/composite IPO +1.12% has soared 61.7% over the past three months, while the iShares Nasdaq Biotechnology ETF /zigman2/quotes/206189322/composite IBB +1.46% has climbed 23.6% and the S&P 500 /zigman2/quotes/210599714/realtime SPX +1.40% has advanced 13.6%.

/zigman2/quotes/219228443/composite
US : U.S.: Nasdaq
$ 24.34
+0.11 +0.45%
Volume: 140,640
Aug. 12, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$791.51 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/207665280/composite
US : U.S.: NYSE Arca
$ 43.16
+0.48 +1.12%
Volume: 46,907
Aug. 12, 2020 4:00p
loading...
/zigman2/quotes/206189322/composite
US : U.S.: Nasdaq
$ 133.81
+1.93 +1.46%
Volume: 3.02M
Aug. 12, 2020 4:00p
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
3,380.35
+46.66 +1.40%
Volume: 2.25B
Aug. 12, 2020 5:10p
loading...

Get news alerts on Nkarta Inc. — or create your own.
This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.